Cannara Biotech Inc (LOVE) — Cash Flow Reinvestment Rate
Cannara Biotech Inc (LOVE) has a Cash Flow Reinvestment Rate of 0.58x as of November 2025, reinvesting CA$4.62 Million (capex CA$4.62 Million ) from operating cash flow of CA$7.96 Million. Check LOVE operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cannara Biotech Inc Cash Flow Reinvestment Rate (2023–2025)
Historical reinvestment intensity for Cannara Biotech Inc across 3 annual periods. Explore cash flow to debt ratio of Cannara Biotech Inc to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Cannara Biotech Inc (2023–2025)
Year-by-year capital reinvestment analysis for Cannara Biotech Inc. For live market cap and broader valuation context, see LOVE stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CAD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.62x | CA$12.31 Million | CA$20.01 Million | CA$6.36 Million | ▼ -48.1% |
| 2024 | 1.18x | CA$12.66 Million | CA$10.68 Million | CA$7.47 Million | ▼ -63.8% |
| 2023 | 3.27x | CA$19.36 Million | CA$5.91 Million | CA$9.88 Million | — |